Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer with poor prognosis, defined by lack of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast cancer.